Resveratrol Mitigates Cognitive Impairments and Cholinergic Cell Loss in the Medial Septum in a Mouse Model of Gradual Cerebral Hypoperfusion

• Hauptverfasser: Eric Fagerli (Verfasst von), Charles W. Jackson (Verfasst von), Iris Escobar (Verfasst von), Fernando J. Ferrier (Verfasst von), Efrain J. Perez Lao (Verfasst von), Isabel Saul (Verfasst von), Jorge Gomez (Verfasst von), Kunjan R. Dave (Verfasst von), Oliver Bracko (Verfasst von), Miguel A. Perez-Pinzon (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2024-08-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Vascular cognitive impairment and dementia (VCID) is the second leading cause of dementia. There is currently no effective treatment for VCID. Resveratrol (RSV) is considered an antioxidant; however, our group has observed pleiotropic effects in stroke paradigms, suggesting more effects may contribu...